Accelerated exposure of phosphatidylserine on lymphocyte populations from patients with systemic lupus erythematosus or rheumatoid arthritis.
Albrecht
Christiane
C
MRC-CSC, Membrane Transport Biology, London, UK.
Soumian
Soni
S
Playford
Raymond
R
Higgins
Christopher F
CF
Vyse
Timothy
T
Elliott
James
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017304:Annexin A5 / Q000737:chemistry; D001172:Arthritis, Rheumatoid / Q000097:blood*; D001692:Biological Transport; D001792:Blood Platelets / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D002118:Calcium / Q000493:pharmacokinetics; D002469:Cell Separation; D003424:Crohn Disease / Q000097:blood* / Q000378:metabolism; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007476:Ionophores / Q000494:pharmacology; D008180:Lupus Erythematosus, Systemic / Q000097:blood*; D008214:Lymphocytes / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010718:Phosphatidylserines / Q000378:metabolism*; D011485:Protein Binding; D013927:Thrombosis / Q000097:blood / Q000175:diagnosis; D013997:Time Factors
D017304:Annexin A5; D007476:Ionophores; D010718:Phosphatidylserines; D002118:Calcium